Animal & Human Health
FDA Final Guidance 209 and 213
Members of the Animal Health Institute (AHI) and the Generic Animal Drug Alliance (GADA) are committed to aligning all affected products with the Food and Drug Administration’s (FDA) policy on judicious use of antibiotics. Under the policy, the growth promotion uses of medically important compounds will be phased out and veterinary oversight of the use of therapeutic products will be phased in.
Successful implementation of this policy means that medically important antibiotics will only be used in food animals under the direction of a veterinarian when there is a specific disease challenge.
For more information about Guidances 209 and 213 and to learn how the animal health industry, producers, and veterinarians are working to prevent antibiotic resistance, visit www.togetherABX.com.